Elisabet De Los Pinos
Chief Executive Officer
Cancer therapy
Aura Biosciences Inc
United States of America
Biography
Eli de los Pinos is the founding CEO of Aura, which she has created from the ground up. Prior to founding Aura, she worked in Eli Lilly & Co.’s oncology business unit. Earlier in her career, Eli worked as a post-doctoral fellow at the Institute of Cancer Research in London. She previously completed fellowships at the Mount Sinai School of Medicine Institute of Molecular Medicine and at the Georgetown School of Medicine. Eli holds a Ph.D., magna cum laude, in Molecular Biology from the University of Barcelona and an MBA from IE Business School. She is a member of the board of overseers at the Museum of Science, Boston. Eli has also been named to Boston Business Journal's 2009 “Top 40 under 40” list; as a Mass High Tech “Woman to Watch” in 2010; as a “Technology Pioneer” by the World Economic Forum in 2010; and as one of Goldman Sachs’ “100 Most Intriguing Entrepreneurs” in 2014.
Research Interest
New class of therapies to target and destroy cancer cells selectively, ocular melanoma, cancer cell biology
